LGA
DGX icon

Lebenthal Global Advisors’s Quest Diagnostics DGX Stock Holding History

Lebenthal Global Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22M Buy
5,743
+217
+4% +$42.6K 0.16% 92
2026
Q1 		$1.08M Buy
5,526
+329
+6% +$63.9K 0.16% 103
2025
Q4 		$902K Buy
5,197
+163
+3% +$29.7K 0.14% 105
2025
Q3 		$959K Buy
5,034
+2,720
+118% +$483K 0.17% 91
2025
Q2 		$416K Buy
2,314
+87
+4% +$15.1K 0.08% 146
2025
Q1 		$377K Buy
+2,227
New +$366K 0.07% 154

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Lebenthal Global Advisors's DGX Position: Q2 2026 in Review

Lebenthal Global Advisors increased its Quest Diagnostics (DGX) stake by 3.9% in Q2 2026, buying an estimated $42.6K and bringing the position to 5,743 shares worth $1.22M. The position accounts for 0.16% of the portfolio, ranked #92.

Lebenthal Global Advisors first reported a position in DGX in Q1 2025 and has held it in 6 quarters since. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Lebenthal Global Advisors held 5,743 shares of Quest Diagnostics worth $1.22M as of Q2 2026.
  • Lebenthal Global Advisors bought 217 Quest Diagnostics shares in Q2 2026, an estimated $42.6K.
  • Quest Diagnostics made up 0.16% of Lebenthal Global Advisors's portfolio in Q2 2026, its #92 holding.
  • Lebenthal Global Advisors first reported a position in Quest Diagnostics in Q1 2025 and has held it in 6 quarters since.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Lebenthal Global Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.